The myelin proteolipid protein gene (PLP1) encodes the most abundant protein present in myelin from the central nervous system (CNS). Its expression must be tightly controlled as evidenced by mutations that alter PLP1 dosage; both overexpression (elevated PLP1 copy number) and lack thereof (PLP1 deletion) result in X-linked genetic disorders in man. However, not much is known about the mechanisms that govern expression of the human gene. To address this, transgenic mice were generated which utilize human PLP1 (hPLP1) sequences (proximal 6.2 kb of 5 0 -flanking DNA to the first 38 bp of exon 2) to drive expression of a lacZ reporter cassette. LoxP sites were incorporated around a 1.5-kb section of hPLP1 intron 1 since it contains sequence orthologous to the wmN1 region from mouse which, previously, was shown to augment expression of a minimallypromoted transgene coincident with the active myelination period of CNS development. Eight transgenic lines were generated with the parental, 6.2hPLP(1)Z/FL, transgene. All lines expressed the transgene appropriately in brain as evidenced by staining with X-gal in white matter regions and olfactory bulb. Removal of the "wmN1" region from 6.2hPLP(1)Z/FL with a ubiquitously expressed Cre-driver caused a dramatic reduction in transgene activity. These results demonstrate for the first time that the wmN1 enhancer region: (1) is functional in hPLP1; (2) works in collaboration with its native promoter-not just a basal heterologous promoter; (3) is required for high levels of hPLP1 gene activity; (4) has a broader effect, both spatially and temporally, than originally projected with mPlp1.
gene must be under tight control. However the pertinent mechanisms that govern expression of hPLP1, specifically, are poorly understood.
Previously we demonstrated with Plp1-lacZ transgenic mice that the first intron of the mouse Plp1 (mPlp1) gene is required in order for the mPlp1 promoter to drive significant levels of lacZ expression in brain (Li, Moore, Dobretsova, & Wight, 2002) . The intron is moderately conserved between human and mouse (60% identity) being a bit larger in hPLP1 (8,579 bp; Hamdan, Kockara, Jolly, Haun, & Wight, 2015) than mPlp1 (8,140 bp; Wight and Dobretsova, 1997) . Overall it comprises more than half of the gene (beginning of exon 1 to the end of exon 7).
In addition to seven major exons, there are a couple of minor exons located within the first intron of PLP1 in human (Sarret et al., 2010) and mouse (Bongarzone et al., 1999; Li et al., 2009) , although the alternatively spliced exons are altogether distinct between human and mouse, and largely (solely for mPlp1) confined to these species. One of the supplementary exons (exon C) from hPLP1 intron 1 lies within sequence orthologous to the mouse wmN1 enhancer region. The mouse wmN1 region consists of 1,171 bp. Its inclusion in a minimally promoted eGFP/ lacZ transgene driven by the heat shock protein (hsp) basal promoter conferred high level expression to the superficial layer of the olfactory bulb as early as postnatal day 0 (P0), and to white matter tracts in brain and spinal cord, coincident with the onset of CNS myelination (Tuason et al., 2008) . However, whether the wmN1 region is capable of acting as an enhancer in conjunction with its native promoter (not just a basal heterologous promoter) was unknown. To address this matter, and to test the importance of intron 1 sequences in general on the regulation of hPLP1 expression, transgenic mice were generated which utilize hPLP1 sequences spanning the proximal 6.2 kb of 5 0 -flanking DNA to the first 38 bp of exon 2 to drive expression of a lacZ reporter gene cassette. A 1.5-kb segment within hPLP1 intron 1, which includes sequence orthologous to the mouse wmN1 region, was flanked by loxP sites for its eventual removal by crossing the parental [6.2hPLP(1)Z/FL] transgenic line with Cre-deleter mice. Results presented here suggest that the "wmN1" region in man plays a pivotal role in regulating hPLP1 expression throughout development.
| M A TE RI A L A ND M E TH ODS

| Transgenic mice
The 6.2hPLP(1)Z/FL transgene is essentially the same as the 6.2hPLP(1) Z plasmid (Hamdan et al., 2015) except for the addition of paired sets of
Frt and loxP sites in hPLP1 intron 1. It utilizes hPLP1 genomic DNA spanning the proximal 6.2 kb of 5 0 -flanking DNA to the first 38 bp of exon 2 to drive expression of a lacZ expression cassette. Bacterial recombination sites were incorporated at opportune restriction enzyme sites (PmlI and BspEI for Frt; XbaI and EcoRI for loxP) in hPLP1 intron 1 through the use of intermediary hPLP1-containing plasmids described in Hamdan et al. (2015) . Plasmid BA8.7, which contains hPLP1 genomic DNA including all of intron 1, was digested with BspEI and ligated to a 5 0 phosphorylated
BspEI adapter that contains an internal Frt site (sense: 5 0 -CCGGAAGTTCCTATTCTCTAGAAAGTATAGGAACTT-3 0 ; antisense: 5 0 -CCGGAAGTTCCTATACTTTCTAGAGAATAGGAACTT-3 0 ) to yield BA8.7(BspEI-Frt). Subsequently, plasmid BA8.7(BspEI-Frt) was digested with SfiI and PmlI, and ligated to a 5 0 phosphorylated SfiI/PmlI adapter which likewise contains an internal Frt site (sense: 5 0 -CACGTGAAGTTC CTATTCTCTAGAAAGTATAGGAACTTC-3 0 ; antisense: 5 0 -GAAGTTCC TATACTTTCTAGAGAATAGGAACTTCACGTGACT-3 0 ). The resulting plasmid was named BA8.7(2-Frt) since it contains two direct repeats of
Frt that are located near the beginning (position 214) and end (position 8,467) of hPLP1 intron 1; the endogenous intron contains a total of 8,579 bp (Hamdan et al., 2015) . LoxP sites were also incorporated at convenient restriction enzyme sites within hPLP1 intron 1 that encompass sequence orthologous to the mouse wmN1 region, including an additional 330 bp of sequence immediately upstream of the "wmN1" region.
At first, a loxP site was added at the (Kilkenny, Browne, Cuthill, Emerson, & Altman, 2010) . Transgenic mice were identified through PCR analysis of genomic DNA isolated from tail biopsies according to the methods of Truett et al. (2000) using the lacZ primer pair described by Stratman, Barnes, and Simon (2003) . In addition, Southern blot analysis was performed to estimate the transgene copy number within the various 6.2hPLP(1)Z/FL lines using a 32 P-labeled lacZ probe (XhoI-NotI fragment from pGALDK), as previously described by Wight, Duchala, Readhead, and Macklin (1993) .
Transgenic sublines that are missing hPLP1 intron positions 3,174-4,660 (6.2hPLPDwmN1) were derived by crossing 6.2hPLP(1)Z/FL hemizygous mice from Lines 776 and 777 with B6.FVB-Tg(EIIa-Cre) C5379Lmgd/J homozygous mice (The Jackson Laboratory; Bar Harbor, ME), and then backcrossing the resulting lacZ-positive progeny with the Cre-deleter strain for two more generations to ensure that the targeted "wmN1" region had been completely removed from all copies of the transgene. The Cre transgene is under the control of the assayed for b-gal activity in triplicate using the Galacto-Light Plus Kit as previously described (Pereira, Meng, Kockara, Yang, & Wight, 2013) .
Lysate protein concentrations were determined using the BCA Protein Assay Kit (Pierce, Rockford, IL). Results are presented as the mean 6 SD of b-gal activity (relative light units; RLU) per lg of total protein from three or more animals for each line/genotype.
In addition to hPLP1-lacZ mouse lines generated here, the relative level of b-gal activity was determined for Line 26H , which harbors a related transgene [PLP(1)Z] that utilizes Plp1 sequences from mouse instead of human. The transgene is referred to here as mPLP(1)Z to indicate the source (species) of Plp1 DNA.
| Combined X-gal staining with immunohistochemistry
6.2hPLP(1)Z/FL mice (Line 777) at P9 of age were anesthetized with isoflurane and perfused intracardially first with cold PBS (pH 7.3), and
then with fixative (2% paraformaldehyde-1% glutaraldehyde in PBS, pH 7.3) for 20 min. Animals were left undisturbed for 40 min, after which the brain, heart, kidneys, liver, lungs, and sciatic nerves were removed and submerged in fixative for 1 hr at 48C. Subsequently, the tissues were incubated in PBS (pH 7.3) containing 10% sucrose at 48C, allowed to sink, transferred to PBS (pH 7.3) containing 25% sucrose overnight at 48C, and then were immersed in CRYO-OCT compound and frozen at 2708C until sectioning on a cryostat. Brain slices (16 lm)
or intact sciatic nerve were subjected to staining with X-gal, followed by immunofluorescence. The X-gal stained sciatic nerve was sectioned longitudinally into 16 lm slices prior to immunofluorescence. The incubation period for staining with X-gal varied between tissues (40 min for brain sections, 30 min for heart, kidney, liver and lung sections, and 20 min for intact sciatic nerve) and was performed at 408C in a water bath. Subsequently, the slides were rinsed three times in PBS (5 min per wash). Antigen retrieval with brain slices was achieved by incubating the sections in 10 mM citrate buffer (pH 6) for 20 min in a 758C
water bath, and then allowing the solution to come to room temperature at the bench. The slices were then washed three times with 1%
Triton X-100 in PBS (5 min To test the importance of intron 1 in regulating hPLP1 gene expression, in vivo, transgenic mice were generated which utilize hPLP1 genomic sequences that span the proximal 6.2 kb of 5 0 -flanking DNA to the first 38 bp of exon 2 to drive expression of a lacZ reporter gene cassette.
Two pairs of short bacterial recombination sites were integrated in the 6.2hPLP(1)Z/FL transgene for the eventual removal of portions of hPLP1 intron 1 (Figure 1 ). LoxP sites were incorporated at intron 1 posi- Figure   S1 ). Crossing 6.2hPLP(1)Z/FL transgenic mice with mice that express
Cre recombinase led to a transgenic subline missing intron 1 positions 3,174-4,660 (designated 6.2hPLPDwmN1), which maintains the same genomic integration site as the parental line from which it was derived.
A total of thirty-five pups (C57BL/6 genetic background) were born from transplanted embryos which had previously been microinjected with the 6.2hPLP (1) (Table 1) . Surprisingly, most of the lines showed comparable or slightly higher amounts of b-gal activity at P2 relative to P21 (Table 1) unlike Line 26H , which harbors a similar transgene [mPLP(1)Z] except that it utilizes mPlp1 genomic DNA (spans proximal 2.4 kb of 5 0 -flanking DNA to the first 37 bp of exon 2) to drive the lacZ reporter; b-gal activity for Line 26H was 20-fold higher at P21 than P2 (Table 1 ).
The 6.2hPLP(1)Z/FL transgene appeared to be expressed appropriately in all lines as evidenced by X-gal staining in white matter areas of brain from mice at P21 ( Figure 2 ); brain slices from Lines 776 and 778 were incubated in X-gal stain longer (6 hr instead of 30 min) due to modest levels of b-gal activity in these lines (see Table 1 ). Because Line 777 expresses 6.2hPLP(1)Z/FL to a relatively high degree in brain, and has a fairly low transgene copy number, this line was selected for subsequent in-depth analysis.
| The 6.2hPLP(1)Z/FL transgene is spatially regulated in line 777
Spatial expression of the 6.2hPLP(1)Z/FL transgene was assessed by qRT-PCR analysis and X-gal staining with mice from Line 777. As shown in Figure 3 , transgene expression at P21 was highest in the CNS (brain and spinal cord), moderate in the peripheral nervous system (PNS; e.g., sciatic nerve), compared to the other tissues tested (heart, kidney, liver, lung, and spleen), which is consistent with endogenous mPlp1 expression (for review see Wight & Dobretsova, 2004) . The negligible amount of transgene expression in heart, kidney, liver, and lung was also confirmed by X-gal staining with tissue sections obtained from mice at P9 (Supporting Information Figure S2 ) and P21 (data not shown), which demonstrated low to nonexistent levels of staining that was equivalent between 6.2hPLP(1)Z/FL mice and wild-type littermates. Conversely, there was ample staining with X-gal in sciatic nerve from P9 transgenic mice, which was absent in wild-type littermates (Supporting Information Figure S3 ). Taken together, these data suggest that the regulatory element(s) responsible for directing the spatial expression of hPLP1 are present in the 6.2hPLP(1)Z/FL transgene.
| Expression of 6.2hPLP(1)Z/FL in brain is developmentally regulated in line 777
To characterize the spatiotemporal expression of 6.2hPLP(1)Z/FL in brain, prior to and during the active myelination period, brains were isolated from mice at P2-P21 of age (Line 777). Mid-sagittal brain slices were subjected to staining with X-gal. As shown in Figure 4 , expression of the 6.2hPLP(1)Z/FL transgene was quite evident at P2, most prominently in the olfactory bulb, neostriatum, corpus callosum (splenium), subventricular zone (SVZ), and developing cerebellum. Expression in the olfactory bulb appeared to lessen over the course of development (P2-P21), while expression in white matter areas occurred primarily in a caudal to rostral direction similar to the pattern previously observed for mPLP(1)Z (Line 26H; Wight et al., 1993) , only expedited.
3.4 | The wmN1 region within hPLP1 intron 1 is essential for robust expression of 6.2hPLP(1)Z/FL in brain
Because Line 777 expresses 6.2hPLP(1)Z/FL strongly in brain and contains only 2-3 copies of the transgene, this line was crossed with Credeleter mice to generate the 6.2hPLPDwmN1 subline. As well, 6.2hPLP
(1)Z/FL mice from Line 776 were used to derive another 6.2hPLPDwmN1 subline; although Line 776 is a relatively low expressor, it contains only a single copy of 6.2hPLP(1)Z/FL, thus eliminating the possibility for any differences between transgene copy number in the parental line and subline. Removal of the wmN1 region from Line 777 greatly diminished transgene activity as shown by the minimal/ lack of X-gal staining in brain with 6.2hPLPDwmN1 mice at P2-P21 of age ( Figure 5 ). In fact, expression of the 6.2hPLPDwmN1 was highest at P2 in the vicinity of the corpus callosum and SVZ, which decreased at P6, and was no longer evident at later ages (P9-P21). This is consistent with the study by Ivanova et al. (2003) where mPlp1gene activity was detected around the lateral ventricle at early postnatal ages. A slight amount of staining was also evident in the olfactory bulb at P6. A developmental decline in the residual amount of b-gal activity present in 6.2hPLPDwmN1 mice was also observed with whole brain lysates;
345 RLU/lg at P2 compared with only 185 RLU/lg at P21 (Table 1 ). In fact, the level of b-gal activity at P21 with the 6.2hPLPDwmN1 subline derived from Line 777 was not much above background, as determined with non-transgenic (wild-type) littermates (Table 1 ). The importance of the wmN1 region was confirmed likewise with Line 776 (Supporting Information Figure S4 ), signifying that the decrease in activity with the 6.2hPLPDwmN1 subline derived from Line 777 is not due, merely, to a (potential) decrease in transgene copy number. sites were introduced at the designated restriction enzyme sites in hPLP1 intron 1; only pertinent restriction enzyme sites are indicated. The loxP sites encase DNA orthologous to the mouse wmN1 enhancer region ('wmN1') and the adjoining 330 bp, upstream. Arrowheads indicate the relative position and orientation of external (black) and internal (gray) primers used to determine whether the "wmN1" region was effectively removed from the transgene after mating 6.2hPLP(1)Z/FL mice with Cre-deleter mice. (b) PCR analysis for production of the 6.2hPLPDwmN1 subline, which was generated by mating 6.2hPLP(1)Z/FL mice (Line 777) to a Cre-deleter strain for several generations to remove the region flanked by loxP sites from all transgene copies. The external primer pair borders the floxed region and results in an amplicon of 422 bp if the targeted sequence is missing (the predicted 1,952 bp product that still retains the floxed sequence is not generated under the conditions utilized for PCR). The internal primer pair amplifies a 759 bp segment within the "wmN1" region and is used to assess whether some copies of the transgene still retain the sequence targeted for removal. As shown for Line 777, a single cross with the Credeleter removed the targeted "wmN1" region from some, but not all, copies of the transgene (13 Cre). However, backcrossing the resulting progeny for two more generations with the Cre-deleter resulted in full excision of the "wmN1" region from all transgene copies (33 Cre) Similar to brain, X-gal staining was greatly diminished (absent) in sciatic nerve when the "wmN1" region was removed from the transgene; compare X-gal staining in intact sciatic nerve from 6.2hPLP(1)Z/ FL mice (Supporting Information Figure S3 ) with that of 6.2hPLPDwmN1 mice (Supporting Information Figure S5 ) at P9 of age (Line 777). Thus, the effect of the wmN1 enhancer is not restricted solely to the CNS.
| The wmN1 region is required for embryonic hPLP1-lacZ expression
Line 777 embryos were incubated in X-gal stain to assess the level of transgene activity during fetal development. b-gal activity was readily apparent at E14.5 in the developing brain, dorsal root ganglia, as well as other areas (e.g., tail and hind limb), in embryos hemizygous for the 6.2hPLP(1)Z/FL transgene, while there was no discernable background (i.e., staining with X-gal) in non-transgenic littermates ( Figure 6 ). Lack of the wmN1 region in 6.2hPLPDwmN1 embryos derived from Line 777 resulted in a complete loss of staining with X-gal at E14.5 ( Figure 6 ) and E17 (data not shown). Thus the wmN1 region appears to be required for hPLP1 gene activity as early as fetal development. Moreover, effects mediated by this regulatory element are not limited solely to the developing nervous system.
3.6 | Colocalization of b-gal activity from 6.2hPLP(1) Z/FL mice with cell type-specific markers
To determine the cell types that express the 6.2hPLP(1)Z/FL transgene, immunohistochemistry was performed following staining with Xgal. Mice from Line 777 at P9 of age were used for these studies. As shown in Figure 7 , the transgene is expressed in oligodendrocyte pre- 
| D ISC USSION
To elucidate the mechanisms that regulate expression of the hPLP1 gene during development, transgenic mice were generated that harbor an hPLP1-lacZ transgene termed 6.2hPLP(1)Z/FL since it utilizes hPLP1 genomic DNA spanning the proximal 6.2 kb of 5 0 -flanking DNA to the first 38 bp of exon 2 to drive expression of a lacZ reporter gene cassette. The transgene encodes a fusion protein with the first 13 amino acids of classic PLP/DM20 attached to the N-terminus of b-gal (PLPand DM20-related products cannot be differentiated as the transgene does not contain hPLP1 exon 3). Because Plp1 intron 1 was shown to be required for expression of a related transgene which contains mPlp1 DNA in lieu of hPLP1 sequences (Li et al., 2002) , bacterial recombination sites were incorporated in 6.2hPLP(1)Z/FL for subsequent removal of portions of hPLP1 intron 1 by mating mice carrying the parental transgene to appropriate deleter strains. We also elected to for the 6.2hPLPDwmN1 subline (Line 777). The mPLP(1)Z transgene is similar to 6.2hPLP(1)Z/FL except it uses mPlp1 genomic DNA (lesser amount) to drive lacZ expression; see Wight et al. (1993) for characterization of Line 26H. b-gal activity is reported as the mean RLU/lg protein 6 SD (n 3) from whole brain homogenates prepared from mice at the indicated postnatal days (P) of age. DNA) since a previous study (Nadon, Arnheiter, & Hudson, 1994) showed that the proximal 4.2 kb of hPLP1 5 0 -flanking DNA drove tissue-specific expression of a PLP cDNA transgene. The 6.2hPLP(1)Z/FL transgene was expressed as early as fetal development in the developing CNS and PNS (Line 777; Figure 6 ) in accordance with an earlier study which detected   FIG URE 3 Spatial expression of the 6.2hPLP(1)Z/FL transgene for Line 777. Total RNA was isolated separately from the indicated tissues of three animals at P21 and subjected to qRT-PCR analysis.
Results are reported as the fold mean 6 SE of lacZ expression (n 5 3) relative to that from the 18S and b-actin reference genes. The plotted amounts are relative to that generated using a pooled sample of brain RNA from all three animals, which was arbitrarily set at 1 (data not shown) FIG URE 4 Developmental expression of the 6.2hPLP(1)Z/FL transgene in brain with Line 777. Mid-sagittal sections (30 lm) from brains of mice at the indicated ages (postnatal days) were subjected to X-gal staining to identify areas of b-gal activity. Sections from animals at P2-P9 were stained for 6 hr, while sections from animals at P12 and P15 were stained for 1 hr, and those from animals at P18 and P21 were stained for only 30 min. Robust staining was detected in the olfactory bulb (far left side of each section) as early as P2. Staining was also evident in white matter areas during development. For instance, note the staining in white matter tracks of the developing cerebellum (cauliflower-shaped region towards the upper right side of each section)
FIGURE 5 Developmental expression of the 6.2hPLPDwmN1 transgene in brain with the 777 subline. Mid-sagittal sections (30 lm) from brains of mice at the indicated ages (postnatal days) were subjected to X-gal staining to identify regions positive for b-gal activity. Sections from animals at P2-P9 were stained for 6 hr, while sections from animals at P12 and P15 were stained for 1 hr, and those from animals at P18 and P21 were stained for 30 min to be consistent with the staining of brain sections from 6.2hPLP(1) Z/FL mice (Figure 4 ). Slight staining was detected in the corpus callosum and SVZ at P2, less so at P6, and virtually undetectable at latter ages. A little bit of staining was also present in the developing olfactory bulb of mice at P2 and P6 (Figure 2 ). b-gal activity was highest in white matter areas and the superficial layer of the olfactory bulb. In fact, expression in the olfactory bulb appeared highest at P2 and seemed to decrease thereafter (out to P21) for Line 777 (Figure 4 ). In rodents, OECs express the Plp1 gene to high degree (Griffiths et al., 1995; Dickinson et al., 1997) .
Immunohistochemistry for GFAP coupled with X-gal staining confirmed that the 6.2hPLP (1) While expression of 6.2hPLP(1)Z/FL in brain was fairly consistent to that of the previously reported mouse-based transgene, mPLP(1)Z , the transgene bearing hPLP1 DNA appeared to be more broadly expressed during fetal and early postnatal development as determined by X-gal staining (Figures 4 and 6 ). This is consistent with the rather substantial level of b-gal activity present in whole brain lysates prepared from P2 mice harboring the 6.2hPLP(1)Z/FL transgene, compared to the relatively low level observed with Line 26H (Table 1) , which contains the mPLP(1)Z transgene. It is possible that some of the extra activity observed for 6.2hPLP(1)Z/FL at P2 originates from neuronal sources due to inclusion of a larger amount of upstream sequence; 6.2hPLP(1)Z/FL contains roughly 3.5 kb more of PLP1 5 0 -flanking DNA than does mPLP(1)Z. In the same study (Tuason et al., 2008) (AB and C) that are incorporated, separately, in splice variants (Sarret et al., 2010) . Utilization of these exons is restricted for the most part to the human species; these isoforms are not expressed in mouse. The "human-specific" splice variants are expressed primarily in neurons and have been detected as early as fetal development (Sarret et al., 2010) .
Due to internal splice donor and acceptor sites within exon AB, two additional splice variants are formed that contain sequence limited to the A-specific region of exon AB, and encode a PLP product having 9 amino acids of additional sequence at the N-terminus. Thus it is possible that the relatively early developmental activity in brain with 6.2hPLP(1)Z/FL (Table 1) terminal domain of b-gal which is necessary for enzymatic activity (Mohler & Blau, 1996) . Previously we have shown that these splice variants are expressed in a mouse-derived oligodendroglial cell line transfected with a related [2.7hPLP(1)Z] plasmid (Hamdan et al., 2015) .
Excision of the wmN1 region from 6.2hPLP(1)Z/FL in Line 777 caused a dramatic reduction in the level of b-gal activity in whole brain homogenates prepared from mice at P2 and P21 (compare 6.2hPLP(1) Z/FL to 6.2hPLPDwmN1 for Line 777 in Table 1 ). Similarly, X-gal staining of mid-sagittal brain slices was diminished in the 6.2hPLPDwmN1
subline at all postnatal ages tested ( Figure 5 ), as well as embryonically ( Figure 6 ). An earlier study showed that the wmN1 region from mouse was able to direct intense expression of a minimally promoted eGFPlacZ transgene to white matter tracts in the brain and spinal cord, and to the superficial layer of the olfactory bulb (Tuason et al., 2008) . Activity of the eGFPlacZ transgene containing wmN1 was detected as early as E15.5 in some of the cells of the emerging olfactory bulb by X-gal staining. A few labeled cells were identified in the cervical spinal cord at E19 and P0, while weak diffuse labeling was detected in most regions of future spinal cord white matter. However, it was unclear from that study whether the wmN1 enhancer region is capable of augmenting expression in conjunction with the native (mPlp1) promoter.
Moreover, mice that possess the rudimentary eGFPlacZ transgene that lacks any mPlp1 sequence inexplicably showed widespread straining with X-gal (Tuason et al., 2008) . Results presented here with the 6.2hPLPDwmN1 subline demonstrate that the wmN1 region is a critical regulatory element that works in association with the hPLP1 promoter to significantly augment expression. While transgene activity in brain was decreased at all postnatal ages examined with the 6.2hPLPDwmN1 subline derived from Line 777, a slight amount of b-gal activity was detected in animals at P2, but essentially lost by P21 (Table 1 and expression. However this apparent discrepancy, at least for the wmN1 enhancer region, could be explained if its mechanism of action was mediated through an effect (in vivo) on chromatin remodeling, which would be of no consequence in transient transfection assays that utilize naked DNA.
It has been known for a long time that inclusion of an intron in a transgene generally has a positive effect on expression levels (Brinster, Allen, Behringer, Gelinas, & Palmiter, 1988; Palmiter, Sandgren, Avarbock, Allen, & Brinster, 1991) . Increased output may be due to augmentation at the level of transcription or, alternatively, at some posttranscriptional step. Many of the steps regulating gene expression have been found to be functionally, and sometimes physically, connected (for review see Orphanides and Reinberg, 2002) . Thus, transgenes that contain intron(s) may have increased output due to a beneficial effect on nuclear export or stability of their mRNA products by virtue of RNA splicing. Splicing signals located near the promoter can enhance gene transcription, directly (Furger, O'sullivan, Binnie, Lee, & Proudfoot, 2002) . While exon C and a portion of exon AB are absent from 6.2hPLPDwmN1, the transgene still contains the promoter proximalmost 5 0 splice site adjoining hPLP1 exon 1. Thus it appears that the most likely explanation for the decrease in activity with the 6.2hPLPDwmN1 subline is due to a loss of a transcriptional enhancer 
